RCS - Accrol Group Hldgs - Online Investor Presentation
RNS Number : 6213IAccrol Group Holdings PLC15 December 2020RNS Reach
15 December 2020
ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")AIM: ACRL
ONLINE INVESTOR PRESENTATION
Accrol Group, one of the UK's leading independent tissue converters, is pleased to announce that following the successful acquisition of Leicester Tissue Company ("LTC") in November 2020, the Group's CEO senior management team is hosting a presentation to provide retail investors with background on Accrol, the Board's strategy and ambitions and the rationale for the acquisition of LTC.
The webinar will take place at 2.00pm today, 15 December 2020, via Zoom.
If you would like to join the webinar, please email georgina@melloevents.com, who will provide login details.
For further information, please contact:
Accrol Group Holdings plc
Dan Wright, Executive Chairman
Via Belvedere Communications
Gareth Jenkins, Chief Executive Officer
Zeus Capital Limited (Nominated Adviser & Broker)
Dan Bate / Jordan Warburton
Tel: +44 (0) 161 831 1512
Dominic King / John Goold
Tel: +44 (0) 203 829 5000
Liberum Capital Limited (Joint Broker)
Tel: +44 (0) 20 3100 2222
Clayton Bush / Edward Thomas
Belvedere Communications Limited
Cat Valentine
Tel: +44 (0) 7715 769 078
Keeley Clarke
Tel: +44 (0) 7967 816 525
Llew Angus
Tel: +44 (0) 7407 023 147
accrolpr@belvederepr.com
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the £1.7bn UK retail tissue market.
This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDNRABIBDDIDBDGGS
Recent news on Accrol group
See all newsREG - Maven Inv Partners Accrol Group Hldgs - Form 8.3 - ACCROL GROUP HOLDINGS PLC
AnnouncementREG - Sarasin & Partners Accrol Group Hldgs - Form 8.3 - Accrol Group Holdings PLC
AnnouncementREG - Decagon Asset Mgmt. Accrol Group Hldgs - Form 8.3 - Accrol Group Holdings Plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Maven Inv Partners Accrol Group Hldgs - Form 8.3 - ACCROL GROUP HOLDINGS PLC
Announcement